Status:
COMPLETED
Cognitive Stimulation in Elderly Individuals at Risk to Develop Dementia (Allena-Mente).
Lead Sponsor:
Fondazione Golgi Cenci
Collaborating Sponsors:
Alzheimer Federation Italy
Camillo Golgi Geriatric Institute
Conditions:
Mild Cognitive Impairment
Healthy Subjects With Family History for Dementia
Eligibility:
All Genders
70-75 years
Phase:
NA
Brief Summary
The Allena-Mente study is a randomized, controlled, single-blind trial assessing the efficacy of cognitive stimulation (CS) compared to an active control group, participating to sanitary education les...
Detailed Description
The experimental protocol was set up with a pilot study on healthy elderly individuals. Data from this pilot study will be excluded from the statistical analysis. Sample size: a priori power analysis...
Eligibility Criteria
Inclusion
- Positive diagnosis for mild cognitive impairment (MCI) according to Petersen's criteria;
- Cognitively healthy elderly individuals, having at least one first-degree relative affected by dementia (Alzheimer's Disease, pre-senile and senile dementia, vascular dementia) (NDFAM).
Exclusion
- (Major physical illness) Compromission of motor performance of lower and upper limbs
- Medical conditions leading to clinical instability;
- Therapies that reduce cognitive and communicative abilities and consciousness;
- Perceptual disorders (sight, hearing)
- Language disorders
- Education level lower than 3 years
- Psychiatric and behavioral disorders
- Addiction to drugs or alcohol
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT01793493
Start Date
March 1 2011
End Date
June 1 2015
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Golgi Cenci Foundation
Abbiategrasso, Milan, Italy, 20081